Related Experiment Video

Updated: Aug 19, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Dyslipidemias in patients who have chronic kidney disease

Kambiz Farbakhsh1, Bertram L Kasiske

  • 1University of Minnesota, Minneapolis, MN 55415, USA. farba002@umn.edu

The Medical Clinics of North America
|March 10, 2005
PubMed

Insights

Patients with chronic kidney disease (CKD) face a high risk of cardiovascular disease (CVD). Current guidelines recommend statin treatment for CKD patients with high LDL, despite limited trial evidence.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Medicine

Background:

  • Patients with chronic kidney disease (CKD) exhibit a significantly elevated risk for developing cardiovascular disease (CVD).
  • A 10-year risk of coronary heart disease events exceeding 20% is common in CKD patients, classifying them in the highest risk category per NCEP ATP III guidelines.

Purpose of the Study:

  • To review current recommendations for managing dyslipidemia in CKD patients.
  • To highlight the need for further evidence-based treatment guidelines for CVD prevention in this population.

Main Methods:

  • Review of National Kidney Foundation K/DOQI guidelines for dyslipidemia management in CKD.
  • Analysis of existing evidence regarding cardiovascular risk and treatment efficacy in CKD patients.

Main Results:

  • K/DOQI guidelines suggest treating CKD patients with LDL ≥ 100 mg/dL with diet and statins.
  • Evidence supporting statin therapy in CKD populations is currently limited, necessitating further placebo-controlled trials.

Conclusions:

  • Despite limited trial data, the high incidence of CVD in CKD patients warrants intensive monitoring and treatment of dyslipidemias.
  • A proactive clinical approach to managing dyslipidemia is reasonable for CKD patients due to their high cardiovascular risk.

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...